Viking Global Investors LP Blueprint Medicines Corp Transaction History

Viking Global Investors LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $17.6 Million - $21.5 Million	-213,050 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $5.41 Million - $6.46 Million	-59,631 Reduced 21.87%	213,050 $20.7 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $107 Million - $144 Million	-1,158,086 Reduced 80.94%	272,681 $30.6 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $13.2 Million - $18.4 Million	-198,949 Reduced 12.21%	1,430,767 $133 Million
Q2 2020 Aug 07, 2020	BUY	$57.09 - $79.27 $1.67 Million - $2.32 Million	29,249 Added 1.83%	1,629,716 $127 Million
Q1 2020 May 13, 2020	BUY	$48.11 - $82.22 $14.1 Million - $24.2 Million	293,926 Added 22.5%	1,600,467 $93.6 Million
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $33.7 Million - $41.7 Million	504,902 Added 62.98%	1,306,541 $105 Million
Q3 2019 Nov 13, 2019	BUY	$72.9 - $101.41 $18.3 Million - $25.4 Million	250,599 Added 45.48%	801,639 $58.9 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $7.91 Million - $10.5 Million	-107,621 Reduced 16.34%	551,040 $52 Million
Q1 2019 May 15, 2019	SELL	$48.7 - $86.6 $26.4 Million - $46.9 Million	-541,661 Reduced 45.13%	658,661 $52.7 Million
Q4 2018 Feb 14, 2019	BUY	$45.57 - $74.26 $49.6 Million - $80.9 Million	1,089,222 Added 980.4%	1,200,322 $64.7 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $6.54 Million - $8.7 Million	111,100 New	111,100 $8.67 Million

350

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.57B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.